TNFRSF11A and bone metastasis: Similarly, median time to bone metastasis progression was significantly shorter (p = 0.0024) in patients with negative slope for RANK-positive CTCs (26.0 months; 95% CI, 14.0–33.0 months) compared to positive slope patients (median time to bone metastasis progression not reached) (Fig. 5B).